UNICYCIVE THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 19.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 19.62M shares, a 4.20% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 18.80M shares, a 83.90% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 18.80M shares, a 10.49% decline year-over-year.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 18.83M shares, a 83.33% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 18.80M shares, a 3.60% decline from fiscal 2024.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 19.50M shares, a 218.25% increase from fiscal 2023.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.13M shares, a 0.00% change from fiscal 2022.
- UNICYCIVE THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.13M shares, a 2.20% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 19.62M shares 10-Q · filed 2026-08-12 | 19.62M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 18.80M shares 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | 18.80M shares 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | 18.80M shares 10-Q · filed 2025-11-12 | 18.80M shares 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | 18.83M shares 10-Q · filed 2026-08-12 | 18.83M shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 10.22M shares 10-Q · filed 2026-05-12 | 102.18M shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | 19.50M shares 10-K · filed 2026-03-30 | 179.41M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 21.00M shares 10-Q · filed 2025-11-12 | 209.99M shares 10-Q · filed 2024-11-13 | 21.00M shares 10-Q · filed 2025-11-12 | 209.99M shares 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | 10.27M shares 10-Q · filed 2025-08-14 | 102.73M shares 10-Q · filed 2024-08-14 | 26.37M shares 10-Q · filed 2025-08-14 | 263.68M shares 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | 176.06M shares 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | 6.13M shares 10-K · filed 2025-03-31 | 176.04M shares 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | 176.06M shares 10-Q · filed 2024-11-13 | 176.06M shares 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | 167.08M shares 10-Q · filed 2024-08-14 | 167.08M shares 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | 163.12M shares 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | 6.13M shares 10-K · filed 2024-03-28 | |||||||
| 2022-09-30 | 5.95M shares 10-Q · filed 2023-11-14 | 5.95M shares 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | 5.96M shares 10-Q · filed 2023-08-14 | 5.96M shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 5.97M shares 10-Q · filed 2023-05-16 | |||||||
| 2021-12-31 | 6.00M shares 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | 5.61M shares 10-Q · filed 2022-11-14 | 5.61M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 660.92K shares 10-Q · filed 2022-08-15 | 660.92K shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 684.32K shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 786.05K shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 786.05K shares 10-Q · filed 2021-11-12 | 786.05K shares 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | 748.84K shares 10-Q · filed 2021-08-16 | 748.84K shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |